Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
Key facts
- Where
- Detroit, United StatesSee the site
Where in United States
- Henry Ford HealthDetroit, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Henry Ford Health System
- Trial code
- NCT07418853
- Record updated
- 11 June 2026
- Original description
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 monthRead full original descriptionShow less
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month
Inclusion: Diagnosed with primary or secondary open-angle glaucoma (e.g., POAG, pigmentary, pseudoexfoliative); Scheduled for phacoemulsification with planned goniotomy; Able to provide informed consent.
Exclusion: Angle-closure glaucoma; Prior glaucoma surgery in the study eye; Planned stand-alone goniotomy; Inability to comply with follow-up schedule.